Skip to main content

Sibold William John's Form 4 filing

Madrigal Pharmaceuticals, Inc. (MDGL) · filed Jul 20, 2026

Accession no.
0001628280-26-048919
Filed
Jul 20, 2026, 9:16 PM ET
Trade date
Jul 17-20, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 11 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.37M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sibold William JohnCIK 0001518611Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 17, 2026Common StockMOption exerciseAcquired+50,000––211,829Direct
Jul 20, 2026Common StockSSaleDisposed−140$542.75−$75,984.43211,689Direct
Jul 20, 2026Common StockSSaleDisposed−110$543.79−$59,817.22211,579Direct
Jul 20, 2026Common StockSSaleDisposed−545$544.71−$296,869.13211,034Direct
Jul 20, 2026Common StockSSaleDisposed−275$545.71−$150,070.03210,759Direct
Jul 20, 2026Common StockSSaleDisposed−269$547.08−$147,164.2210,490Direct
Jul 20, 2026Common StockSSaleDisposed−680$547.70−$372,434.64209,810Direct
Jul 20, 2026Common StockSSaleDisposed−47$548.87−$25,796.98209,763Direct
Jul 20, 2026Common StockSSaleDisposed−153$550.01−$84,152.11209,610Direct
Jul 20, 2026Common StockSSaleDisposed−1$550.72−$550.72209,609Direct
Jul 20, 2026Common StockSSaleDisposed−280$555.05−$155,414209,329Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 17, 2026Common StockMOption exerciseDisposed−50,000$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)